Posterior urethral valves are obstructing membranes in the urethra of baby boys that can cause bladder outlet obstruction. They are the most common cause of bladder outlet obstruction in newborns. Initial management involves bladder drainage, antibiotics, and monitoring for metabolic and electrolyte abnormalities. Definitive treatment is endoscopic ablation of the valves to relieve obstruction, with vesicostomy being an alternative approach. Long-term risks include renal insufficiency, hypertension, and salt-losing nephropathy. Prognosis depends on factors like initial renal function and presence of reflux.
Presentation delivered at a paediatric clinical meeting of the Federal Medical Center, Lokoja. Nigeria
This presentation doesn't serve as a substitute for texts and/or journals.
Presentation delivered at a paediatric clinical meeting of the Federal Medical Center, Lokoja. Nigeria
This presentation doesn't serve as a substitute for texts and/or journals.
POSTERIOR URETHRAL VALVES- Pediatric Surgery
• Dear viewers,
• Greetings from “ Surgical Educator”
• Today I have uploaded one more video in Pediatric Surgery/Pediatric Urology- “ Posterior Urethral Valves”
• Posterior Urethral Valves is the congenital cause for Bladder Outlet Obstruction, resulting in abnormal development of the kidneys as well as the bladder.
• In this video, I talked about the learning outcomes, introduction, etiopathogenesis, clinical features, investigations, differential diagnosis, treatment, follow-up and prognosis of “ Posterior Urethral Valves”
• I hope you will enjoy the video for its educational value.
• You can watch all my teaching videos in the following links
• surgicaleducator.blogspot.com youtube.com/c/surgicaleducator
• Thank you for watching the video.
POSTERIOR URETHRAL VALVES- Pediatric Surgery
• Dear viewers,
• Greetings from “ Surgical Educator”
• Today I have uploaded one more video in Pediatric Surgery/Pediatric Urology- “ Posterior Urethral Valves”
• Posterior Urethral Valves is the congenital cause for Bladder Outlet Obstruction, resulting in abnormal development of the kidneys as well as the bladder.
• In this video, I talked about the learning outcomes, introduction, etiopathogenesis, clinical features, investigations, differential diagnosis, treatment, follow-up and prognosis of “ Posterior Urethral Valves”
• I hope you will enjoy the video for its educational value.
• You can watch all my teaching videos in the following links
• surgicaleducator.blogspot.com youtube.com/c/surgicaleducator
• Thank you for watching the video.
Vesicoureteric reflux , a common condition in children which could be misdiagnosed . Early diagnosis can help prevent renal scarring and other complications
Small intestine/Intestinal obstruction/crohns disease/ileostomy/viscous organ...RajeevPandit10
all about small intestine, anatomy, physiology, intestinal obstruction, crohns disease/ileostomy/viscous organ perforation, meckels diverticulum, mysenteric ischemia, short bowel syndrome, celiac disease
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. Posterior Urethral Valves
• Posterior urethral valves are obstructing membranes within
the lumen of the urethra, extending from the
verumontanum .
• Occur only in boys.
• Commonest cause of bladder outlet obstruction
5. Types
• Type I:
Obstructing membrane that extends distally from each side of
the verumontanum towards the membranous urethra where they
fuse anteriorly
6.
7.
8. Type II
Described as folds extending cephalad from the verumontanum to
the bladder neck
9. Type III
Represent a diaphragm or ring-like membrane with a central
aperture just distal to the verumontanum
10.
11. Epidemiology
• INCIDENCE: 1/ 5000 – 8,000 male infants.
• GENETICS: debatable, but have been seen in siblings. Males only
• Type I > 95%
• Type III - 5%
• Children with Type III PUVs have a worse prognosis as a group
• 50% of patients with PUV will have vesicoureteral reflux
• 50% unilateral, 50% bilateral
12. Antenatal Diagnosis & Management
2/3 of the patient diagnosed antenatally
Distended, thick walled bladder.
Hydronephrosis.
Dilated prostatic urethra (Keyhole sign)
Oligohydramnios : Most of the amniotic fluid after the 16th
gestation depend on the fetal urine
Oligohydramnios would suggest primary renal impairment or
obstruction.
Oligohydramnios - accounts for co-presentation of pulmonary
hypoplasia
13. In fetus with suspected PUV and normal
amniotic fluid , serial sonograms are necessary
Oligohydramnios
VAS
Gestational Age
> 32 Weeks < 32 Weeks
Early Delivery Endoscopic Ablation
14. Before Intervention
• Karyotyping
• To confirm male gender
• Chromosomal Abnormalities
• Fetal Renal function Assessment
• Urinary Electrolytes
• B2 microglobulin level
15. Clinical Presentation
POST- NATAL DIAGNOSIS:
Time and mode of presentation would depend on the severity of the condition
Newborn
Palpable abdominal mass
Distended bladder, hydronephrotic kidney
Bladder may feel like a small walnut in the suprapubic area
Ascites
40% of time due to obstructive uropathy
History of Oligohydramnios
Respiratory distress from pulmonary hypoplasia
Severity often does not correlate with degree obstruction
Primary cause of death in newborns
16. Clinical Presentation
Early Infancy
Dribbling / poor urinary stream
Urosepsis
Dehydration
Electrolyte abnormalities
Uremia
Failure to thrive; due to renal insufficiency
Toddlers
Better renal function (less obstruction)
Febrile UTI
Voiding dysfunction – incontinence
Daytime incontinence may be the only symptom in boys with less severe
obstruction
18. Features on VCUG
1. Dilated, thick walled, trabeculated bladder
2. Elongated and dilated prostatic urethra with narrow bladder neck.
3. Folds of valves could be seen as filling defects from the area of the
verumontanum.
4. VUR, diverticula.
22. DMSA Scan
• Thin or abnormal parenchyma on USG
• High grade VUR
• Study should delay until 6-8 weeks to allow maturation of
renal function
23. Initial managment
A - Bladder Drainage
• A 5 or 8 Fr pediatric feeding tube is ideal
• A Foley catheter should not be used, due to the tendency of the balloon to occlude the ureteral orifice
and cause a bladder spasm.
• Secondary obstruction
B - Broad spectrum antibiotic coverage
C - Metabolic panel
• Assess renal function and metabolic abnormalities
• Acidosis, hyperkalemia common problems
D - Pulmonary resuscitation
E - If urinary ascities - paracentesis
24. Treatment
Endoscopic Valve Ablation
• Should be done after stabilization of neonate
• An 8 French or 9.5 French cystoscope is used with bugbee
electrode
• Leaflets should be incised at 5 and 7 o’clock position (12 o'clock)
• Following valve ablation feeding tube is left for one to two days
• Follow up after two to four weeks with USG and VCUG
• Renal function should be monitor carefully
• Complication : incomplete valve ablation , stricture formation,
iatrogenic hypospadias
25. Vesicostomy and delayed valves ablation
• Alternative to Valve Ablation
• Indications
• Pediatric cystoscope is too large
• Severe hydroureteronephrosis
• Urinary ascities
• High grade VUR
• Poor renal function
• Most popular technique is Blocksom
• Valve ablation should not be performed at the time to vesicostomy
26.
27. Temporary upper tract diversion
• Reserve for rare cases in which
valve ablation or vesicostomy
fail to improve upper tract drainage
• Sober –en-T ureterostomy is preferred method
28. Management of Urinary Ascities
• Rupture of renal fornix with urinary extravasation and transduction in
to peritoneum can occur.
• Infant can develop perirenal urinoma or urinary ascities.
• Electrolytes abnormalities can result from urinary absorption.
• Evaluation begin with USG, VCUG, renal Scintigraphy
• Inserting a 5 French or 8 French feeding tube into the bladder may
decompress the bladder and upper urinary tract sufficiently that the
forniceal extravasation stops.
• Percutaneous drainage is needed if the extravasation and the serum
creatinine continue to increase, or respiratory compromise.
30. Follow-up After Initial Therapy
• Antibiotic prophylaxis should be continued until the upper tract
dilation improves.
• Periodic follow-up with ultrasound, electrolyte measurements
• Early treatment with anticholinergic therapy (oxybutynin) may also be
beneficial.
31. Prognosis
Favourable
• Serum creatinine concentration
less than 0.8 mg/dL one month
after initial treatment, or at age 1
year.
• Visualization of the
corticomedullary junction
differentiation
• Achieving diurnal continence by
the age of 5 years
• Presence of a pressure pop-off
mechanism
• Normal appearance of the
contralateral kidney at diagnosis.
• Absence of reflux on the initial
VCUG
Unfavorrable